Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia

被引：6
|
作者：
Blombery, Piers [1 ,2 ,3 ]
Anderson, Mary Ann [1 ,2 ,3 ,4 ]
Gong, Jianan [1 ,4 ]
Thijssen, Rachel [1 ,4 ]
Birkinshaw, Richard W. [1 ,4 ]
Thompson, Ella [1 ,3 ]
Teh, Charis E. [1 ,4 ]
Nguyen, Tamia [3 ]
Xu, Zhen [4 ]
Flensburg, Christoffer [4 ]
Lew, Thomas [4 ]
Majewski, Ian [4 ]
Gray, Daniel [4 ]
Westerman, David Alan [1 ,2 ,3 ]
Tam, Constantine S. [1 ,2 ,3 ]
Seymour, John F. [1 ,2 ,3 ]
Czabotar, Peter E. [1 ,4 ]
Huang, David [1 ,4 ]
Roberts, Andrew W. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Univ Melbourne, Melbourne, Vic, Australia
[2] Royal Melbourne Hosp, Melbourne, Vic, Australia
[3] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[4] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia
[5] Victorian Comprehens Canc Ctr, Melbourne, Vic, Australia
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-120761
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
LBA-7
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia
    Blombery, Piers
    Anderson, Mary Ann
    Gong, Jia-nan
    Thijssen, Rachel
    Birkinshaw, Richard W.
    Thompson, Ella R.
    Teh, Charis E.
    Nguyen, Tamia
    Xu, Zhen
    Flensburg, Christoffer
    Lew, Thomas E.
    Majewski, Ian J.
    Gray, Daniel H. D.
    Westerman, David A.
    Tam, Constantine S.
    Seymour, John F.
    Czabotar, Peter E.
    Huang, David C. S.
    Roberts, Andrew W.
    CANCER DISCOVERY, 2019, 9 (03) : 342 - 353
  • [2] Acquisition of the recurrent Gly101Val mutation in BCL2 confers resistance to venetoclax in patients with progressive chronic lymphocytic leukemia (Comment to Tausch et al.)
    Weiss, Jonathan
    Peifer, Martin
    Herling, Carmen D.
    Frenzel, Lukas P.
    Hallek, Michael
    HAEMATOLOGICA, 2019, 104 (11) : E540 - E540
  • [3] Acquisition of the recurrent Gly101Val mutation in BCL2 confers resistance to venetoclax in patients with progressive chronic lymphocytic leukemia (Comment to Tausch et al.) Response
    Tausch, Eugen
    Stilgenbauer, Stephan
    HAEMATOLOGICA, 2019, 104 (11) : E542 - E542
  • [4] Multiple BCL2 mutations cooccurring with Gly101Val emerge in chronic lymphocytic leukemia progression on venetoclax
    Blombery, Piers
    Thompson, Ella R.
    Tamia Nguyen
    Birkinshaw, Richard W.
    Gong, Jia-Nan
    Chen, Xiangting
    McBean, Michelle
    Thijssen, Rachel
    Conway, Thomas
    Anderson, Mary Ann
    Seymour, John F.
    Westerman, David A.
    Czabotar, Peter E.
    Huang, David C. S.
    Roberts, Andrew W.
    BLOOD, 2020, 135 (10) : 773 - +
  • [5] Detection of Multiple Recurrent Novel BCL2 Mutations Co-Occurring with BCL2 Gly101Val in Patients with Chronic Lymphocytic Leukemia on Long Term Venetoclax
    Blombery, Piers
    Thompson, Ella
    Tamia Nguyen
    Chen, Xiangting
    McBean, Michelle
    Birkinshaw, Richard W.
    Czabotar, Peter E.
    Thijssen, Rachel
    Anderson, Mary Ann
    Seymour, John F.
    Westerman, David Alan
    Huang, David C. S.
    Roberts, Andrew W.
    BLOOD, 2019, 134
  • [6] Gly101Val BCL2 Mutation: One Step Closer to Understanding Venetoclax Resistance in CLL
    Thangavadivel, Shanmugapriya
    Byrd, John C.
    CANCER DISCOVERY, 2019, 9 (03) : 320 - 322
  • [7] Venetoclax resistance and acquired BCL2 mutations in chronic lymphocytic leukemia
    Tausch, Eugen
    Close, William
    Dolnik, Anna
    Bloehdorn, Johannes
    Chyla, Brenda
    Bullinger, Lars
    Doehner, Hartmut
    Mertens, Daniel
    Stilgenbauer, Stephan
    HAEMATOLOGICA, 2019, 104 (09)
  • [8] Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
    Roberts, Andrew W.
    Davids, Matthew S.
    Pagel, John M.
    Kahl, Brad S.
    Puvvada, Soham D.
    Gerecitano, John F.
    Kipps, Thomas J.
    Anderson, Mary Ann
    Brown, Jennifer R.
    Gressick, Lori
    Wong, Shekman
    Dunbar, Martin
    Zhu, Ming
    Desai, Monali B.
    Cerri, Elisa
    Enschede, Sari Heitner
    Humerickhouse, Rod A.
    Wierda, William G.
    Seymour, John F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (04): : 311 - 322
  • [9] Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia
    Guarente, Valerio
    Martino, Giovanni
    Dorillo, Erica
    De Falco, Filomena
    Rompietti, Chiara
    Sorcini, Daniele
    Brogna, Mariangela
    Cardinali, Valeria
    Ascani, Stefano
    Marra, Andrea
    Sportoletti, Paolo
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] Progress in BCL2 inhibition for patients with chronic lymphocytic leukemia
    Tam, Constantine S.
    Seymour, John F.
    Roberts, Andrew W.
    SEMINARS IN ONCOLOGY, 2016, 43 (02) : 274 - 279
12345